The approval is based on results from the Phase III FLOW trial demonstrating Ozempic reduced the risk of severe kidney outcomes by 24% compared to placebo, including kidney failure, reduction in ...
The new indication makes Ozempic the first glucagon-like peptide-1 receptor agonist (GLP-1RA) available for people with T2D ...
Smartphones are taking a shot at slenderizing in a nod to Ben Stiller’s itty-bitty mobile in the early-aughts classic ...
SLOWLY lifting her head off her sweat-drenched pillow, Aisleyne Horgan-Wallace vomits into the sick bucket next to her bed. ...
Pennsylvania-based pharmaceutical firm Provepharm Inc is voluntarily recalling vials of phenylephrine hydrochloride, which is ...